INmune Bio, Inc. (INMB)
1.275
+0.06
(+5.37%)
USD |
NASDAQ |
Jun 11, 16:00
1.26
-0.02
(-1.18%)
After-Hours: 19:32
INmune Bio Price : 1.275 for June 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jun 10, 2026 | 1.23 | 1.255 | 1.200 | 1.21 | 207065.0 |
| Jun 09, 2026 | 1.26 | 1.295 | 1.202 | 1.22 | 262685.0 |
| Jun 08, 2026 | 1.28 | 1.28 | 1.24 | 1.24 | 294480.0 |
| Jun 05, 2026 | 1.37 | 1.37 | 1.24 | 1.26 | 328109.0 |
| Jun 04, 2026 | 1.31 | 1.395 | 1.31 | 1.35 | 312607.0 |
| Jun 03, 2026 | 1.41 | 1.42 | 1.305 | 1.32 | 391936.0 |
| Jun 02, 2026 | 1.42 | 1.535 | 1.39 | 1.42 | 1.046M |
| Jun 01, 2026 | 1.40 | 1.425 | 1.36 | 1.39 | 181639.0 |
| May 29, 2026 | 1.39 | 1.43 | 1.33 | 1.41 | 303325.0 |
| May 28, 2026 | 1.40 | 1.435 | 1.37 | 1.42 | 212009.0 |
| May 27, 2026 | 1.42 | 1.455 | 1.395 | 1.40 | 218645.0 |
| May 26, 2026 | 1.46 | 1.48 | 1.40 | 1.43 | 241102.0 |
| May 22, 2026 | 1.47 | 1.50 | 1.435 | 1.45 | 170505.0 |
| May 21, 2026 | 1.41 | 1.45 | 1.37 | 1.44 | 252196.0 |
| May 20, 2026 | 1.42 | 1.455 | 1.38 | 1.41 | 257740.0 |
| May 19, 2026 | 1.47 | 1.495 | 1.40 | 1.41 | 326855.0 |
| May 18, 2026 | 1.55 | 1.565 | 1.455 | 1.49 | 346710.0 |
| May 15, 2026 | 1.66 | 1.68 | 1.540 | 1.55 | 870254.0 |
| May 14, 2026 | 1.59 | 1.79 | 1.500 | 1.68 | 4.276M |
| May 13, 2026 | 1.39 | 1.49 | 1.355 | 1.46 | 209157.0 |
| May 12, 2026 | 1.34 | 1.41 | 1.31 | 1.39 | 346997.0 |
| May 11, 2026 | 1.43 | 1.43 | 1.35 | 1.35 | 159022.0 |
| May 08, 2026 | 1.41 | 1.505 | 1.41 | 1.43 | 240374.0 |
| May 07, 2026 | 1.53 | 1.535 | 1.43 | 1.43 | 312072.0 |
| May 06, 2026 | 1.54 | 1.58 | 1.46 | 1.52 | 409212.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Sangamo Therapeutics, Inc. | 0.149 |
| Arrowhead Pharmaceuticals, Inc. | 74.40 |
| Oncolytics Biotech, Inc. | 0.8228 |
| Sarepta Therapeutics, Inc. | 15.00 |
| Anixa Biosciences, Inc. | 2.49 |
Price Related Metrics
| Price to Book Value | 1.727 |
| Earnings Yield | -132.9% |
| Market Cap | 33.90M |